Skip to main content
. 2020 Aug 21;24:516. doi: 10.1186/s13054-020-03240-7

Table 2.

Incidence of ARDS, IMV treatment, and outcomes in COVID-19 patients admitted to an ICU

Study author, online publication datea Location ICU patients with ARDS ICU patients who received IMV Mortality ICU patients Mortality ARDS patients Mortality IMV patients Prevalence of ARDS in non-survivors
Dreher M, 17/4 Aachen, Germany 24/24 (100) 24/24 (100) 3/24 (13) 3/24 (13) 3/24 (13) 3/7 (43)
Yao Q, 24/4 Huanggang, China 17/17 (100) 10/17 (59) 12/17 (71) 12/45 (27) 10/10 (100) 12/12 (100)
Hong K, 11/5 Daegu, South Korea 13/13 (100) 11/13 (85) 4/13 (31) 4/18 (22) NA 4/5 (80)
Xu X,19/2 Zhejiang, China 1/1 (100) 1/1 (100) 0/1 (0) 0/1 (0) 0/1 (0) NA
Wu C, 13/3 Wuhan, China NA 6/53 (11) NA 44/84 (52) 6/6 (100) 44/44 (100)
Zhou F, 11/3 Wuhan, China NA NA 39/50 (78) 50/59 (85) 31/32 (97) 50/54 (93)
Zheng Y, 10/4 Chengdu, China 15/32 (47) NA 3/32 (9) 3/15 (20) NA 3/3 (100)
Suleyman G, 1/6 Detroit, Michigan, USA 104/141 (74) 114/141 (81) 57/141 (40) NA 52/114 (46) NA
Huang C, 24/1 Wuhan, China 11/13 (85) 4/13 (31) 5/13 (38) NA NA NA
Wang D, 7/2 Wuhan, China 22/36 (61) 21/36 (58) 6/36 (17) NA NA NA
Yang L, 26/5 Yichang, China 21/29 (72) 16/29 (55) 14/29 (48) NA NA NA
Chen T, 26/3 Wuhan, China NA NA NA 113/196 (58) 17/17 (100) 113/113 (100)
Aggarwal S, 26/4 Des Moines, Iowa, USA NA 5/8 (63) 3/8 (38) NA NA NA
Inciardi R, 8/5 Brescia, Italy NA NA NA 17/19 (89) NA 17/26 (65)
Chen N, 30/1 Wuhan, China NA NA NA 11/17 (65) NA 11/11 (100)
Ciceri F, 12/6 Milan, Italy NA NA NA 65/245 (27) NA 65/82 (79)
Yu T, 27/4 Dongguan, China NA NA NA NA NA NA
Total (weighted average) 228/306 (75) 212/335 (63) 146/363 (40) 322/722 (45) 119/203 (59) 322/357 (90)

Data are presented as n/N(%)

Abbreviations: ARDS acute respiratory distress syndrome, COVID-19 coronavirus disease 2019, ICU intensive care unit, IMV invasive mechanical ventilation, NA not available: insufficient data for calculation

aFor study reference see Table 1